Back

Vericiguat in the management of heart failure with reduced ejection fraction

European Heart Journal - Cardiovascular Pharmacotherapy

25 May 2021
Organised by: Logo
Read full article
ESC Journals

Contributors

Haya Aziz
Haya Aziz

Author

Pishoy Gouda
Pishoy Gouda

Author

Abhinav Sharma
Abhinav Sharma

Author

McGill University Health Centre Montreal , Canada

You may be interested in
thumbnail
Congress Session
Pioneering advances in HFrEF management: unlocking the potential of sGC stimulation
18 May 2025
thumbnail
Congress Presentation
Vericiguat clinical pharmacology programme: biopharmaceutical properties and potential intrinsic and extrinsic factor effects
28 August 2020
thumbnail
Congress Presentation
Effects of vericiguat on redox signaling in cardiomyocyte
28 August 2023
thumbnail
Congress Presentation
Sacubitril/valsartan is associated with improved pulmonary haemodynamics in patients with heart failure with reduced ejection fraction
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources